Trial
NCT01964755
Chemotherapy for Relapsed Epstein Barr Virus Associated Lymphoma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Miami
Collaborators
—
Condition
Epstein Barr Virus Associated Non Hodgkin's Lymphoma
Intervention
Doxorubicin
Why stopped
Investigator Decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-09-23